HIGHLIGHTS
- What: This study demonstrated a mechanism linking EGFR signalling with Fyn and Src activation to promote tumour progression and invasion and provided a rationale for combined anti-EGFR and anti-SFK targeted therapies (Lu et_al, 2009).
- Who: Arturo Mangas and collaborators from the University of Salamanca, Spain have published the research: Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours, in the Journal: (JOURNAL)
- Future: To improve the prognosis of cancer patients more research is necessary to understand the activation and inactivation of Fyn as well as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.